全文获取类型
收费全文 | 4384篇 |
免费 | 157篇 |
国内免费 | 35篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 82篇 |
妇产科学 | 63篇 |
基础医学 | 558篇 |
口腔科学 | 62篇 |
临床医学 | 249篇 |
内科学 | 1088篇 |
皮肤病学 | 48篇 |
神经病学 | 331篇 |
特种医学 | 193篇 |
外科学 | 879篇 |
综合类 | 19篇 |
预防医学 | 83篇 |
眼科学 | 190篇 |
药学 | 232篇 |
中国医学 | 8篇 |
肿瘤学 | 467篇 |
出版年
2023年 | 19篇 |
2022年 | 15篇 |
2021年 | 88篇 |
2020年 | 44篇 |
2019年 | 63篇 |
2018年 | 72篇 |
2017年 | 59篇 |
2016年 | 97篇 |
2015年 | 97篇 |
2014年 | 135篇 |
2013年 | 173篇 |
2012年 | 283篇 |
2011年 | 302篇 |
2010年 | 138篇 |
2009年 | 131篇 |
2008年 | 257篇 |
2007年 | 293篇 |
2006年 | 257篇 |
2005年 | 286篇 |
2004年 | 292篇 |
2003年 | 282篇 |
2002年 | 287篇 |
2001年 | 51篇 |
2000年 | 49篇 |
1999年 | 62篇 |
1998年 | 47篇 |
1997年 | 55篇 |
1996年 | 49篇 |
1995年 | 56篇 |
1994年 | 54篇 |
1993年 | 60篇 |
1992年 | 37篇 |
1991年 | 41篇 |
1990年 | 27篇 |
1989年 | 28篇 |
1988年 | 23篇 |
1987年 | 16篇 |
1986年 | 20篇 |
1985年 | 18篇 |
1984年 | 16篇 |
1983年 | 22篇 |
1982年 | 19篇 |
1981年 | 19篇 |
1980年 | 16篇 |
1979年 | 9篇 |
1978年 | 15篇 |
1977年 | 9篇 |
1976年 | 11篇 |
1974年 | 12篇 |
1971年 | 8篇 |
排序方式: 共有4576条查询结果,搜索用时 15 毫秒
1.
Hirokazu Miki Shingen Nakamura Masahiro Oura Hirofumi Hamano Kenji Ikuta Naoto Okada Yasunobu Okamoto Kimiko Sogabe Mamiko Takahashi Masami Iwasa Kengo Udaka Takeshi Harada Kiyoe Kurahashi Shiro Fujii Sumiko Yoshida Kumiko Kagawa Itsuro Endo Ken-ichi Aihara Masahiro Abe 《British journal of haematology》2019,186(2):355-358
2.
Yang Liu Yoshifumi Baba Takatsugu Ishimoto Hiroyasu Tsutsuki Tianli Zhang Daichi Nomoto Kazuo Okadome Kensuke Yamamura Kazuto Harada Kojiro Eto Yukiharu Hiyoshi Masaaki Iwatsuki Yohei Nagai Shiro Iwagami Yuji Miyamoto Naoya Yoshida Yoshihiro Komohara Masaki Ohmuraya Xiaoming Wang Jaffer A. Ajani Tomohiro Sawa Hideo Baba 《British journal of cancer》2021,124(5):963
Background Fusobacterium nucleatum (F. nucleatum) is a gut microbe implicated in gastrointestinal tumorigenesis. Predicting the chemotherapeutic response is critical to developing personalised therapeutic strategies for oesophageal cancer patients. The present study investigated the relationship between F. nucleatum and chemotherapeutic resistance in oesophageal squamous cell carcinoma (ESCC).Methods We examined the relationship between F. nucleatum and chemotherapy response in 120 ESCC resected specimens and 30 pre-treatment biopsy specimens. In vitro studies using ESCC cell lines and co-culture assays further uncovered the mechanism underlying chemotherapeutic resistance.Results ESCC patients with F. nucleatum infection displayed lesser chemotherapeutic response. The infiltration and subsistence of F. nucleatum in the ESCC cells were observed by transmission electron microscopy and laser scanning confocal microscopy. We also observed that F. nucleatum modulates the endogenous LC3 and ATG7 expression, as well as autophagosome formation to induce chemoresistance against 5-FU, CDDP, and Docetaxel. ATG7 knockdown resulted in reversal of F. nucleatum-induced chemoresistance. In addition, immunohistochemical studies confirmed the correlation between F. nucleatum infection and ATG7 expression in 284 ESCC specimens.Conclusions F. nucleatum confers chemoresistance to ESCC cells by modulating autophagy. These findings suggest that targeting F. nucleatum, during chemotherapy, could result in variable therapeutic outcomes for ESCC patients.Subject terms: Tumour biomarkers, Oesophageal cancer 相似文献
3.
Yusuke Kagawa Hiromi Furuta Takehiro Uemura Naohiro Watanabe Junichi Shimizu Yoshitsugu Horio Hiroaki Kuroda Yoshitaka Inaba Takeshi Kodaira Katsuhiro Masago Shiro Fujita Akio Niimi Toyoaki Hida 《Cancer science》2020,111(12):4442
Immune checkpoint inhibitors (ICIs) have dramatically changed the strategy used to treat patients with non‐small‐cell lung cancer (NSCLC); however, the vast majority of patients eventually develop progressive disease (PD) and acquire resistance to ICIs. Some patients experience oligoprogressive disease. Few retrospective studies have evaluated clinical efficacy in patients with oligometastatic progression who received local therapy after ICI treatment. We conducted a retrospective analysis of advanced NSCLC patients who received PD‐1 inhibitor monotherapy with nivolumab or pembrolizumab to evaluate the effects of ICIs on the patterns of progression and the efficacy of local therapy for oligoprogressive disease. Of the 307 patients treated with ICIs, 148 were evaluated in our study; 42 were treated with pembrolizumab, and 106 were treated with nivolumab. Thirty‐eight patients showed oligoprogression. Male sex, a lack of driver mutations, and smoking history were significantly correlated with the risk of oligoprogression. Primary lesions were most frequently detected at oligoprogression sites (15 patients), and 6 patients experienced abdominal lymph node (LN) oligoprogression. Four patients showed evidence of new abdominal LN oligometastases. There was no significant difference in overall survival (OS) between the local therapy group and the switch therapy group (reached vs. not reached, P = .456). We summarized clinical data on the response of oligoprogressive NSCLC to ICI therapy. The results may help to elucidate the causes of ICI resistance and indicate that the use of local therapy as the initial treatment in this setting is feasible treatment option. 相似文献
4.
5.
6.
7.
Tetsuji Terazawa Takeshi Kato Masahiro Goto Katsuya Ohta Shingo Noura Hironaga Satake Yoshinori Kagawa Hisato Kawakami Hiroko Hasegawa Kazuhiro Yanagihara Tatsushi Shingai Ken Nakata Masahito Kotaka Masayuki Hiraki Ken Konishi Shiro Nakae Daisuke Sakai Yukinori Kurokawa Toshio Shimokawa Taroh Satoh 《The oncologist》2021,26(1):17-e47
Lessons Learned
- Panitumumab monotherapy showed favorable efficacy and feasibility in the treatment of frail or elderly patients with RAS wild‐type unresectable colorectal cancer.
- It is especially effective for left‐sided tumors; therefore, panitumumab as first‐line treatment could be an additional therapeutic option for frail elderly patients, particularly in those who are unsuitable for upfront oxaliplatin‐based or irinotecan‐based combination regimens.
8.
9.
This study examined the effects of conditions (that is, the fee structure and the easy of obtaining a dental appointment) on patient understanding and cooperation in clinical practice for dental hygiene and dental students. A questionnaire was given sequentially to 1483 patients attending the Tokyo Medical and Dental University dental hospital on "clinical education and patient satisfaction". Direct participants consisted of 650 patients, of which 213 (32.8%) were male and 422 (64.9%) female. The remaining 15 (2.3%) did not specify their gender. Patients who were satisfied with care received by dentists tended to be older compared to patients who were dissatisfied with dentists. The difference was significant (p < 0.001). Acceptable conditions for patients such as fees and appointments at the clinical session had an effected on patient acceptance of clinical training. The findings of this study suggest that patient satisfaction should be considered as part of the reasons for patients accepting dental care by students in their clinical education programs. Fees and appointment schedules strongly affect patient acceptance of clinical education. 相似文献
10.
The purpose of this study was to evaluate how the different mechanical properties of two luting agents (acrylic resin cement and resin composite cement) influenced their bond strength to dentin, after cyclic loading that simulated chewing. Stainless steel rods were bonded to the flattened dentin surfaces with each luting agent. After immersion in water for 24 hours, half the specimens of each group were tested for tensile bond strength and the remaining half were subjected to a vertical load (75.6 N, 1.2 Hz) using an acrylic stylus--which upon contact with the specimen would rotate counterclockwise and then counter-rotate. Bond strength of the resin composite cement with self-etching was found to be significantly lower than the other adhesive systems. After 100,000 cycles, the bond strength of resin composite cement was significantly decreased while acrylic resin cement showed no decrease in bond strength. 相似文献